Venetoclax,Ibrutinib
Roche,Abbvie,Janssen,Pharmacyclics
['cll', ' ibru']
congress | #ash22
paolo ghia presented a poster on use of 1st line ibrutinib in pts with cll. data were pooled from 3 studies in pts with previously untreated cll. 3 and 5 year estimated os was significantly higher in pts treated with long-term ibrutinib vs ct.
#medicalcongress 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm